Menu
Back to Journals » Nutrition and Dietary Supplements » Volume 13
Potential Nutraceuticals for COVID-19
Authors Savant S, Srinivasan S, Kruthiventi AK
Received 29 November 2020
Accepted for publication 8 January 2021
Published 18 February 2021 Volume 2021:13 Pages 25—51
DOI https://doi.org/10.2147/NDS.S294231
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Gary Johanning
Sayali Savant, Shraddha Srinivasan, Anil Kumar Kruthiventi
Arna Immuno Ingredients Private Limited, Mumbai, Maharashtra, India
Correspondence: Anil Kumar Kruthiventi
Arna Immuno Ingredients Private Limited, 1st Floor, 41/44, Minoo Desai Marg, Colaba, Mumbai, 400005, India
Tel +91 954 550 0481
Fax +91 22 674 900 001
Email anil.kumar@arnaimmuno.com
Abstract: SARS-CoV-2 infection has caused, and is continuing to cause, considerable human suffering. Studies on the viral pathogenesis has resulted in convergent findings from several lines of evidence on the entry and spread of the virus in the host. These studies have also revealed a strong association between innocuous inflammation, ageing and metabolic disorders, with SARS-CoV-2 infection and its prognosis. Diet helps modulate inflammation, and nutraceuticals can inhibit viral entry. Hence, we have collated literature on antiviral nutraceuticals effective against other similar coronaviruses. The objective of this study is to comprehensively review available information on the antiviral activity of nutraceuticals and to discuss the implications of these findings in designing a diet that would boost the innate immunity and act as preventive care against COVID-19. This review highlights the fundamental impact of nutraceuticals and diet on inhibition of viral entry and provides a new perspective on the prevention and treatment of COVID-19.
Keywords: SARS-CoV-2, diet, plant protease inhibitors, polyphenols, bioactive peptides
This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.